Transdermal Integrated Actuator Device, Methods of Making and Using Same
First Claim
Patent Images
1. A method for delivering a drug to a patient comprising the steps of:
- a. forming one or more micropores in a tissue membrane of said patient with a poration device, the poration device comprising;
i. an outer body defining a top of said poration device, said outer body containing a cavity;
ii. a controller board comprising driving electronics and a battery, said controller board being positioned within said cavity; and
iii. a tissue interface layer for contacting a tissue membrane of the patient, said tissue interface layer containing at least one probe element, wherein each at least one probe element is a heated resistive element configured to conductively deliver thermal energy to cause ablation of the tissue to a desired depth for formation of the micropore, and wherein said tissue interface layer forms a portion of the bottom of said poration device;
b. removing the poration device; and
c. applying a patch comprising a drug to a microporated area of the tissue membrane after poration.
9 Assignments
0 Petitions
Accused Products
Abstract
The invention provides for an integrated device for forming a cavity in a surface of a tissue of an animal comprising: a) a controller board connected to an energy source for actuating at least one porator; b) a fluid reservoir in fluid communication with the tissue; and c) a tissue interface layer, the tissue interface layer containing the at least one porator, the porator in contact with the tissue for forming the cavity. The invention also provides for methods of making and methods of using the same.
114 Citations
46 Claims
-
1. A method for delivering a drug to a patient comprising the steps of:
-
a. forming one or more micropores in a tissue membrane of said patient with a poration device, the poration device comprising; i. an outer body defining a top of said poration device, said outer body containing a cavity; ii. a controller board comprising driving electronics and a battery, said controller board being positioned within said cavity; and iii. a tissue interface layer for contacting a tissue membrane of the patient, said tissue interface layer containing at least one probe element, wherein each at least one probe element is a heated resistive element configured to conductively deliver thermal energy to cause ablation of the tissue to a desired depth for formation of the micropore, and wherein said tissue interface layer forms a portion of the bottom of said poration device; b. removing the poration device; and c. applying a patch comprising a drug to a microporated area of the tissue membrane after poration. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A transdermal drug delivery patch system for delivering a drug across a tissue membrane comprising:
-
a. an actuator; b. a porator removably connected to said actuator, said porator comprising at least one microporator which is actuated by said actuator and forms at least one micropore in said tissue membrane;
wherein each at least one microporator is a heated resistive element configured to conductively deliver thermal energy to cause ablation of the tissue membrane to a desired depth for formation of a cavity in the tissue membrane; andc. a patch comprising a drug, said patch being applied to a microporated area of said tissue membrane after poration. - View Dependent Claims (11, 12, 13, 14, 15)
-
-
16. An integrated poration device comprising:
-
a. a poration device comprising; i. an outer body defining a top of said poration device, said outer body containing a cavity; ii. a controller board comprising driving electronics and a battery, said controller board being positioned within said cavity; and iii. a tissue interface layer for contacting a tissue membrane of an animal, said tissue interface layer containing at least one probe element, wherein each at least one probe element is a heated resistive element configured to conductively deliver thermal energy to cause ablation of the tissue to a desired depth for formation of the micropore said tissue interface layer forming the bottom of said poration device; and b. a patch comprising a drug, said patch being applied to a microporated area of said tissue membrane after poration. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24)
-
-
25. A method for delivering a drug to a patient comprising the steps of:
-
a. forming one or more micropores in a tissue membrane of said patient with a poration device, the poration device comprising; i. an outer body defining a top of said poration device, said outer body containing a cavity; ii. a controller board comprising driving electronics, said controller board being positioned within said cavity; and iii. a tissue interface layer for contacting a tissue membrane of the patient, said tissue interface layer comprising a thin film defining a plurality of probe elements, wherein each at least one probe element is a heated resistive element configured to conductively deliver thermal energy to cause ablation of the tissue to a desired depth for formation of the micropore(s), and wherein said tissue interface layer forms a portion of the bottom of said poration device; b. removing the poration device; and c. applying a patch comprising a drug to a microporated area of the tissue membrane after poration - View Dependent Claims (26, 27, 28)
-
-
29. A method for delivering a drug to a patient comprising the steps of:
-
a. forming one or more micropores in a tissue membrane of said patient with a poration device, the poration device comprising a tissue interface layer configured for contacting the tissue membrane and selectively forming a plurality of micropores within the tissue membrane, the tissue interface layer comprising a thin film, wherein the thin film comprises a plurality of probe elements that are configured for selective formation of the plurality of micropores, wherein each probe element of the plurality of probe elements is a heated resistive element that is configured to conductively deliver thermal energy to cause ablation of the tissue to a desired depth for formation of one micropore in the tissue membrane; and b. removing the poration device and c. applying a patch to a microporated area of the tissue membrane after poration. - View Dependent Claims (30, 31)
-
-
32. A transdermal drug delivery patch system for delivering a drug across a tissue membrane comprising:
-
a. an actuator; b. a porator array removably connected to the actuator, the porator array comprising a plurality of microporators which is actuated by the actuator to form a plurality of micropores in the tissue membrane;
wherein each microporator of the plurality of microporators comprises a heated resistive element configured to conductively deliver thermal energy to cause ablation of the tissue membrane to a desired depth for formation of one micropore in the tissue membrane; andc. a patch comprising a drug, said patch being applied to a microporated area of said tissue membrane after poration. - View Dependent Claims (33, 34, 35, 36, 37, 38)
-
-
39. A poration system for selective formation of a plurality of micropores within a tissue membrane of an animal, comprising:
-
a. an outer body defining a cavity; b. a controller board comprising driving electronics, said controller board being positioned within said cavity; c. a thin film configured for contacting the tissue membrane, wherein the thin film comprises a plurality of probe elements that are configured for selective formation of the plurality of micropores, wherein each probe element of the plurality of probe elements is a heated resistive element that is configured to conductively deliver thermal energy to cause ablation of the tissue to a desired depth for formation of one micropore in the tissue membrane, and wherein the thin film is in select electrical communication with the controller board; and d. a patch comprising a drug, said patch being applied to a plurality of micropores in the tissue membrane after poration. - View Dependent Claims (40, 41, 42, 43, 44, 45)
-
-
46. A method for delivering a drug to a patient comprising the steps of:
-
a. forming one or more micropores in a tissue membrane of said patient with a poration device, the poration device comprising; i. an outer body defining a top of said poration device, said outer body containing a cavity; ii. a controller board comprising driving electronics and a battery, said controller board being positioned within said cavity; and
a tissue interface layer for contacting a tissue membrane of the patient, said tissue interface layer containing at least one probe element, wherein each at least one probe element is a heated resistive element configured to conductively deliver thermal energy to cause ablation of the tissue to a desired depth for formation of the micropore, and wherein said tissue interface layer forms a portion of the bottom of said poration device;b. removing the poration device; and c. applying a patch comprising a drug to a microporated area of the tissue membrane after poration, wherein said patch is a permeable solid structure, wherein said permeable solid structure is a porous polymer.
-
Specification